Prediction of neurological diseases by using autoantibodies: Wishful thinking come true

Israel Medical Association Journal

Volumn 10, Issue 1, 2008, Pages 29-31

  Zifman, Eyal ^a,b   Amital, Howard ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoantibodies; Autoimmunity; Epilepsy; Multiple sclerosis; Myasthenia gravis

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; BIOLOGICAL MARKER;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; COMPLEMENT CLASSICAL PATHWAY; DISEASE MARKER; EPILEPSY; HUMAN; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; NONHUMAN; PATIENT IDENTIFICATION; REVIEW; RISK ASSESSMENT; ANIMAL; IMMUNOLOGY; MASS SCREENING; METABOLISM; METHODOLOGY;

ANIMALS; AUTOANTIBODIES; BIOLOGICAL MARKERS; EPILEPSY; HUMANS; MASS SCREENING; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS;

EID: 41149147595     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Quintana FJ, Pitashny M, Cohen IR. Experimental autoimmune myasthenia gravis in naive non-obese diabetic (NOD/LtJ) mice: susceptibility associated with natural IgG antibodies to the acetylcholine receptor. Int Immunol 2003;15:11-16.
2. Tuzun E, Saini SS, Ghosh S, Rowin J, Meriggioli MN, Christadoss P. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis. Neuromuscul Disord 2006;16:137-43.
3. Gardnerova M, Eymard B, Morel E, et al. The fetal/adult acetylcholine receptor antibody ratio in mothers with myasthenia gravis as a marker for transfer of the disease to the newborn. Neurology 1997; 48:50-4.
4. Berger T, Rubner P, Schautzer F, et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003;349:139-45.
5. Rauer S, Euler B, Reindl M, Berger T. Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event. J Neurol Neurosurg Psychiatry 2006;77:739-42.
6. Antel JP, Bar-Or A. Do myelin-directed antibodies predict multiple sclerosis? N Engl J Med 2003;349:107-9.
7. Menge T, Lalive PH, von Budingen HC, Cree B, Hauser SL, Genain CP. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis. J Allergy Clin Immunol 2005;116:453-9.
8. Lampasona V, Franciotta D, Furlan R, et al. Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects. Neurology 2004;62:2092-4.
9. Lefranc D, Almeras L, Dubucquoi S, de SJ, Vermersch P, Prin L. Distortion of the self-reactive IgG antibody repertoire in multiple sclerosis as a new diagnostic tool. J Immunol 2004;172:669-78.
10. Xiao BG, Linington C, Link H. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J Neuroimmunol 1991;31:91-6.
11. Gaertner S, de Graaf KL, Greve B, Weissert R. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis. Neurology 2004;63:2381-3.
12. Haase CG, Guggenmos J, Brehm U, et al. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J Neuroimmunol 2001;114:220-5.
13. McKnight K, Jiang Y, Hart Y, et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005;65:1730-6.
14. Ganor Y, Freilinger M, Dulac O, Levite M. Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines. Autoimmunity 2005;38:139-50.
15. Eriksson K, Peltola J, Keranen T, Haapala AM, Koivikko M. High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases. Epilepsy Res 2001;46:129-37.
16. Krause I, Leibovici L, Blank M, Shoenfeld Y. Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis. Lupus 2007;16:176-80.
17. Peltola JT, Haapala A, Isojarvi JI, et al. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Am J Med 2000;109:712-17.